|  | Iranian | Chinese | South Asian | Other | P |
---|---|---|---|---|---|---|
Sex (N = 2873) | Male | 10 (71.4%) | 94 (74.6%) | 57 (47.9%) | 1821 (69.7%) | p < 0.001 |
 | Female | 4 (28.6%) | 32 (25.4%) | 62 (52.1%) | 793 (30.3%) |  |
Age in years (N = 2873) | Less than 55 | 0 (0.0%) | 14 (11.1%) | 21 (17.6%) | 314 (12.0%) | 0.12 |
 | 55-64 | 1 (7.1%) | 35 (27.8%) | 32 (26.9%) | 610 (23.3%) |  |
 | 65-74 | 9 (64.3%) | 41 (32.5%) | 35 (29.4%) | 858 (32.8%) |  |
 | 75 and More | 4 (28.6%) | 36 (28.6%) | 31 (26.1%) | 832 (31.8%) |  |
Years of Diagnosis (N = 2873) | 1984-1990 | 3 (21.4%) | 16 (12.7%) | 22 (18.5%) | 486 (18.6%) | 0.164 |
 | 1991-1995 | 1 (7.1%) | 26 (20.6%) | 15 (12.6%) | 580 (22.2%) |  |
 | 1996-2000 | 3 (21.4%) | 38 (30.2%) | 33 (27.7%) | 637 (24.4%) |  |
 | 2001-2006 | 7 (50%) | 46 (36.5%) | 49 (41.2%) | 911 (34.9%) |  |
Tumor Histology (N = 2873) | SCC * | 5 (35.7%) | 103 (81.7%) | 81 (68.1%) | 1389 (53.1%) | p < 0.001 |
 | AC ** | 7 (50.0%) | 19 (15.1%) | 27 (22.7%) | 1101 (42.1%) |  |
 | Other | 2 (14.3%) | 4 (3.2%) | 11 (9.2%) | 124 (4.8%) |  |
Tumor Location (N = 2873) | Upper 1/3 | 2 (14.3%) | 23 (18.3%) | 17 (14.3%) | 314 (12.0%) | p < 0.001 |
 | Middle 1/3 | 1 (7.1%) | 45 (35.7%) | 34 (28.6%) | 605 (23.1%) |  |
 | Lower 1/3 | 9 (64.3%) | 40 (31.7%) | 51 (42.9%) | 1383 (52.9%) |  |
 | NES/NOS*** | 2 (14.3%) | 18 (14.3%) | 17 (14.3%) | 312 (12.0%) |  |
Tumor Stage (N = 2594) | I | 1 (8.3%) | 12 (10.3%) | 8 (7.6%) | 212 (9.0%) | 0.84 |
 | II | 6 (50.0%) | 66 (56.9%) | 56 (53.3%) | 1363 (57.8%) |  |
 | III | 3 (25.0%) | 27 (23.3%) | 26 (24.8%) | 459 (19.4%) |  |
 | IV | 2 (16.7%) | 11 (9.5%) | 15 (14.3%) | 326 (13.8%) |  |
Surgery (N = 2830) | Yes | 2 (15.4%) | 24 (19.2%) | 35 (29.9%) | 630 (24.5%) | 0.23 |
 | No | 11 (84.6%) | 101 (80.8%) | 82 (70.1%) | 1944 (75.5%) |  |
Chemotherapy (N = 2820) | Yes | 0 (0.0%) | 39 (31.2%) | 25 (21.6%) | 526 (20.5%) | 0.0084 |
 | No | 13 (100.0%) | 86 (68.8%) | 91 (78.4%) | 2039 (79.5%) |  |
Radiotherapy (N = 2853) | Yes | 13 (100.0%) | 112 (89.6%) | 111 (93.3%) | 2240 (86.3%) | 0.052 |
 | No | 0 (0.0%) | 13 (10.4%) | 8 (6.7%) | 355 (13.7%) |  |